Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $2.33 Analyst target: $12.08 Upside: 418.45%
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
See the full interactive analysis & chart →Informational only — not investment advice.